- Investing Ideas
- /
- Swiss Pharmaceuticals & Biotech Sustainable Track Record
Swiss Pharmaceuticals & Biotech Sustainable Track Record
Results
2
0 new
Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.
2 companies
SKAN Group
Market Cap: CHF 1.4b
Provides isolators, cleanroom devices, and decontamination processes for pharmaceutical and chemical industries in Europe, the Americas, Asia, and internationally.
SKAN
CHF 61.10
7D
-1.5%
1Y
-25.7%
Basilea Pharmaceutica
Market Cap: CHF 478.5m
Engages in the discovering, developing, and commercializing drugs for bacterial or fungal infections.
BSLN
CHF 39.45
7D
-1.7%
1Y
-2.5%